Vitafoods Insights is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Is now the right time to launch an immunity product? – podcast

Consumer sales show spikes in supplements and products for immune health in light of the coronavirus outbreak. Similarly, some brands are looking to strike while the iron’s hot. Launching an immune health product that is safe, high quality and true to its label claims involves a careful and thoughtful process, and with the market in saturated state, is now the right time to be launching a product for immune health?

Blaž Gorjup, founder and chairman of private label company, PharmaLinea, discusses the current state of the immune health category together with Charlotte Bastiaanse:

  • Strategy considerations for brands looking to accelerate an immune health product to market 
  • Time and risk factors considerations for product development 
  • Product differentiation in a competitive marketplace
  • Protecting brand integrity and adjusting messaging in light of the COVID-19 crisis
  • Gaps for opportunity and innovation within the immune health category when markets return to normal
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish